JAK2 and non-small cell lung carcinoma: For instance, BAs activate the FXR receptor, thereby promoting the metastasis of non-small cell lung cancer (NSCLC) by mediating the JAK2/STAT3 signaling pathway through the transactivation of IL-6ST and IL-6 genes [104].